The Societal and Patient-Level Burden of Sickness Absenteeism in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Across Two Decades in Slovenia
References
- Jacobs P, Bissonnette R, Guenther LC. Socioeconomic burden of immune-mediated inflammatory diseases – focusing on work productivity and disability. J Rheumatol. 2011;38 Suppl 88:55–61. doi: 10.3899/jrheum.110901.
- Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229. doi: 10.1186/ar2669.
- Batko B, Rolska-Wójcik P, Władysiuk M. Indirect costs of rheumatoid arthritis depending on type of treatment-a systematic literature review. Int J Environ Res Public Health. 2019;16(16):2966. doi: 10.3390/ijerph16162966.
- Kawalec P, Malinowski KP. The indirect costs of psoriatic arthritis: Systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2015;15(1):125–132. doi: 10.1586/14737167.2015.965154.
- Malinowski KP, Kawalec P. The indirect costs of ankylosing spondylitis: A systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2015;15(2):285–300. doi: 10.1586/14737167.2015.1001370.
- Filipovic I, Walker D, Forster F, Curry AS. Quantifying the economic burden of productivity loss in rheumatoid arthritis. Rheumatology. 2011;50(6):1083–1090. doi: 10.1093/rheumatology/keq399.
- Hsieh PH, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S. Economic burden of rheumatoid arthritis: A systematic review of literature in biologic era. Ann Rheum Dis. 2020;79(6):771–777. doi: 10.1136/annrheumdis-2019-216243.
- Yuasa A, Yonemoto N, Kamei K, Murofushi T, LoPresti M, Taneja A, et al. Systematic literature review of the use of productivity losses/gains in cost-effectiveness analyses of immune-mediated disorders. Adv Ther. 2022;39(12):5327–5350. doi: 10.1007/s12325-022-02321-z.
- D’Angiolella LS, Cortesi PA, Lafranconi A, Micale M, Mangano S, Cesana G, et al. Cost and cost effectiveness of treatments for psoriatic arthritis: A systematic literature review. Pharmacoeconomics. 2018;36(5):567–589. doi: 10.1007/s40273-018-0618-5.
- Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006;65(9):1175–1183. doi: 10.1136/ard.2005.046367.
- Lenssinck MLB, Burdorf A, Boonen A, Gignac MA, Hazes JMW, Luime JJ. Consequences of inflammatory arthritis for workplace productivity loss and sick leave: A systematic review. Ann Rheum Dis. 2013;72(4):493–505. doi: 10.1136/annrheumdis-2012-201998.
- Antczak E, Miszczyńska KM. Measuring and assessing sick absence from work: A European cross-sectional study. Comp Econ Res. 2023;26(4):187–211. doi: 10.18778/1508-2008.26.37.
- Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: Results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis. 2010;69(10):1803–1808. doi: 10.1136/ard.2009.122101.
- Mau W, Thiele K, Lamprecht J. Trends of work force participation of patients with rheumatic diseases. Z Rheumatol. 2014;73(1):11–19. doi: 10.1007/s00393-013-1205-y.
- Huscher D, Mittendorf T, von Hinüber U, Kötter I, Hoese G, Pfäfflin A, et al. Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis. 2015;74(4):738–745. doi: 10.1136/annrheumdis-2013-204311.
- Huscher D, Thiele K, Rudwaleit M, Albrecht KC, Bischoff S, Krause A, et al. Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012. RMD Open. 2015;1(1):e000033. doi: 10.1136/rmdopen-2014-000033.
- Stolwijk C, Castillo-Ortiz JD, Gignac M, Luime J, Boonen A. Importance of contextual factors when measuring work outcome in ankylosing spondylitis: A systematic review by the OMERACT worker productivity group. Arthritis Care Res. 2015;67(9):1316–1327. doi: 10.1002/acr.22573.
- Nielsen C, Petersson IF, Jacobsson LTH, Jöud A. Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis. Rheumatol Int. 2018;38(2):275–282. doi: 10.1007/s00296-017-3809-z.
- Westerlund H, Ferrie J, Hagberg J, Jeding K, Oxenstierna G, Theorell T. Workplace expansion, long-term sickness absence, and hospital admission. Lancet. 2004;363(9416):1193–1197. doi: 10.1016/S0140-6736(04)15949-7.
- European Commission. State aid cases: Slovenia [internet]. 2025 [cited 2025 Jun 1]. Available at:
https://commission.europa.eu/strategy-and-policy/coronavirus-response/supporting-jobs-and-economy-during-coronavirus-pandemic/state-aid-cases/slovenia_en - Rotar Ž, Tomšič M, Praprotnik S. The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs-BioR x.si. Clin Rheumatol. 2019;38(2):297–305. doi: 10.1007/s10067-018-4324-7.
- Kvien TK, Balsa A, Betteridge N, Buch MH, Durez P, Favalli EG, et al. Considerations for improving quality of care of patients with rheumatoid arthritis and associated commorbidities. RMD Open. 2020;6(2):e001211. doi: 10.1136/rmdopen-2020-001211.
- Nikiphorou E, Buch MH, Hyrich KL. Biologics registers in RA: Methodological aspects, current role and future applications. Nat Rev Rheumatol. 2017;13(8):503–510. doi: 10.1038/nrrheum.2017.81.
- Nacionalni inštitut za javno zdravje. Evidenca začasne / trajne odsotnosti z dela zaradi bolezni, poškodb, nege, spremstva in drugih vzrokov (NIJZ 3) [internet]. 2025 [cited 2025 Jun 1]. Available at:
https://podatki.nijz.si/docs/1_07_Bolniška_odsotnost.pdf - Eurostat. NACE Rev. 2 – Statistical classification of economic activities [internet]. 2025 [cited 2025 Jun 1]. Available at:
https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-07-015 - Eurostat. Employment – annual statistics [internet]. 2025 [cited 2025 Jun 1]. Available at:
https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Employment_-_annual_statistics - Statistični urad Republike Slovenije. Podatkovna baza SiStat [internet]. 2025 [cited 2025 Jun 1]. Available at:
https://pxweb.stat.si/SiStat/sl/Podrocja/Index/139/delo-in-brezposelnost - Statistični urad Republike Slovenije. Strukturna statistika plač. 2023 [cited 2026 Jan 2]. Available at:
https://www.stat.si/statweb/File/DocSysFile/8153 - Oblak M, Lotrič Dolinar A, Rotar Ž, Tomšič M, Došenović Bonča P. Research data for the article »The societal and patient-level burden of sickness absenteeism in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis across two decades in Slovenia« [Internet]. Geneva: Zenodo; 2026. [cited 2026 Apr 13]. Available at:
https://doi.org/10.5281/zenodo.19551939 - Mastekaasa A. Absenteeism in the public and the private sector: Does the public sector attract high absence employees? J Publ Adm Res Theor. 2020;30(1):60–76. doi: 10.1093/jopart/muz003.
- Ehlert, A García-Morán E. Workers’ self-selection into public sector employment: A tale of absenteeism. Kyklos. 2022;75(3):394–409. doi: 10.1111/kykl.12300.
- Alomari A, Alqudah Q, Maule G, Mestarihi A, Al-Omari S, Obeidat O, et al. Impact of seropositivity on mortality and extra-articular manifestations in rheumatoid arthritis: A nationwide propensity-matched cohort study. Mediterr J Rheumatol. 2025;36(4):616–627. doi: 10.31138/mjr.150425.smr.
- Passia E, Vis M, Coates LC, Soni A, Tchetverikov I, Gerards AH, et al. Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res Ther. 2022;24(1):22. doi: 10.1186/s13075-021-02680-y.
- Hansen SM, Hetland ML, Pedersen J, Østergaard M, Rubak TS, Bjorner JB. Work ability in rheumatoid arthritis patients: A register study on the prospective risk of exclusion and probability of returning to work. Rheumatology. 2017;56(7):1135–1143. doi: 10.1093/rheumatology/kex064.
- ter Wee MM, Lems WF, Usan H,, Gulpen A, Boonen A. The effect of biological agents on work participation in rheumatoid arthritis patients: A systematic review. Ann Rheum Dis. 2012;71(2):161–171. doi: 10.1136/ard.2011.154583.
- Park HS, del Campo PD, Plana MN, La Borda JPY, Guerra-Rodríguez M, Moreno M, et al. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: Systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Front Med. 2025;12:1621313. doi: 10.3389/fmed.2025.1621313.
- Tang K, Escorpizo R, Beaton DE, Bombardier C, Lacaille D, Zhang W, et al. Measuring the impact of arthritis on worker productivity: Perspectives, methodologic issues, and contextual factors. J Rheumatol. 2011;38(8):1776–1790. doi: 10.3899/jrheum.110405.
- Frieden TR. Evidence for health decision making – beyond randomized, controlled trials. N Engl J Med. 2017;377(5):465–475. doi: 10.1056/NEJMra1614394.
- Tillett W, Bojke L. Work disability and the cost-effectiveness of drugs to treat rheumatic diseases – time for a new dialogue? J Rheumatol. 2018;45(8):1075–1077. doi: 10.3899/jrheum.180197.
Language: English
Page range: 122 - 131
Submitted on: Nov 19, 2025
Accepted on: Apr 21, 2026
Published on: Jun 1, 2026
Published by: National Institute of Public Health, Slovenia
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Mitja Oblak, Aleša Lotrič Dolinar, Žiga Rotar, Matija Tomšič, Petra Došenović Bonča, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution 4.0 License.